MNM Bioscience Inc. Company
MNM integrates cutting-edge genomics with the latest breakthroughs in AI to fight cancer. Our goal is to crack the code of tumor biology
Founded Date:
2018-03-01
Total Funding:
4477022
Investor Type:
contact@mnm.bio
Employee Number:
11-50
Funding Status:
Seed
Technology:
['BioTech & HealthTech', 'AI Infrastructure']
Last Funding Type:
Grant
Investors Number:
2.0
Last Funding Date:
2020-10-20
Industry:
Medical BioTech
Headquarters:
Cambridge, Massachusetts, United States